Oklahoma Center for the Advancement of Science and Technology; requiring certain commitments before awarding certain contracts for health research projects; providing for exception. Effective date.
Impact
The bill modifies Sections 5060.16 and 5060.17 of Title 74 of the Oklahoma Statutes, instituting stricter criteria for awarding professional service contracts. Key stipulations include a requirement that investigators be residents of Oklahoma or become residents within 90 days post-funding. Furthermore, the institutions administering contracts must be based in Oklahoma, thereby promoting state-centric research activities and potentially enhancing local economic benefits.
Summary
SB214 is a legislative bill aimed at amending existing statutes regarding the funding and administration of health research projects through the Oklahoma Center for the Advancement of Science and Technology (OCAST). Specifically, the bill seeks to ensure that funding is allocated based solely on the scientific merit of proposed projects. It outlines the center's responsibilities in managing these funds, emphasizing accountability and efficiency in health research initiatives.
Sentiment
Overall sentiment surrounding SB214 appears favorable, particularly among legislative members who advocate for strong scientific standards and local involvement in research funding. Supporters argue that the bill will improve the quality of health research funded by ensuring accountability from recipients. However, there could be concerns raised regarding the restrictions imposed on researchers and institutions, particularly those based out of state, which may see this as a barrier to collaborative efforts.
Contention
Notably, potential points of contention could arise from the mandates that prohibit contract transfers to out-of-state institutions and strictly limit fund expenditure for patient care unless intrinsic to the contract. Critics might argue that these provisions could hinder broader collaborative health initiatives that involve out-of-state researchers or institutions. The effectiveness and feasibility of tracking compliance with funding outcomes over multiple years may further fuel debate.
Carry Over
Oklahoma Center for the Advancement of Science and Technology; requiring certain commitments before awarding certain contracts for health research projects; providing for exception. Effective date.
Oklahoma Center for the Advancement of Science and Technology; requiring certain commitments before awarding certain contracts for health research projects; providing for exception. Effective date.
State government; creating the Oklahoma Center for the Advancement of Science and Technology Program Modernization Act; modifying powers and duties; effective date.
Oklahoma Center for the Advancement of Science and Technology; making appropriations; source; amount; purpose; compliance; reports; requiring appearance before certain joint committee; emergency.
Oklahoma Center for the Advancement of Science and Technology; creating the Accelerator Program; establishing the Accelerator Revolving Fund; effective date; emergency.
Oklahoma Central Purchasing Act; acquisition initiation; adding exemption for certain contracts from competitive bidding requirements; requiring State Purchasing Director to review and audit all exceptions; effective date.
Sales tax; providing exemption for certain nonprofits that train rescue dogs and first responders. requiring certain training sufficiency. Effective date.
Behavioral health; requiring health insurer to cover certain out-of-network services under certain circumstances; providing exceptions. Effective date.
Oklahoma Center for the Advancement of Science and Technology; requiring certain commitments before awarding certain contracts for health research projects; providing for exception. Effective date.
Mandates insurance policies, provides coverage to diagnose & treat infertility for women between 25 & 42 years, including pre-implantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).
Mandates all insurance contracts, plans or policies provide insurance coverage for the expense of testing and treating infertility, including preimplantation genetic testing (PGT), in conjunction with in vitro fertilization (IVF).
Mandates all insurance contracts, plans or policies provide insurance coverage for the expense of diagnosing and treating infertility, for women between the ages of 25 and 42 years including preimplantation genetic diagnosis (PGD) in conjunction with IVF.
Mandates insurance policies, provides coverage to diagnose & treat infertility for women between 25 & 42 years, including pre-implantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).